WallStreetZen

NASDAQ: ENDP
Endo International plc Earnings & Revenue

ENDP past revenue growth

How has ENDP's revenue growth performed historically?
Company
-5.84%
Industry
18.26%
Market
41.43%
ENDP's revenue has grown slower (-5.26% per year) than the US Drug Manufacturers - Specialty & Generic industry average (25.52%)
Performance
ENDP's revenue has grown slower (-5.26% per year) than the US market average (19.54%)
Performance
ENDP's revenue growth is slowing down - its growth over the last year (-5.84%) is below its 5-year compound annual rate (-5.26%)
Performance

ENDP earnings and revenue history

Current Revenue
$2.8B
Current Earnings
$69.5M
Current Profit Margin
2.5%
ENDP's has not demonstrated consistent long-term earnings growth over the past 10 years (-86.49%)
Performance

ENDP Return on equity

Current Company
-10.5%
Current Industry
-85.8%
Current Market
23.1%
ENDP's Return on Equity (-10.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ENDP Return on assets

Current Company
0.8%
Current Industry
1.8%
ENDP is generating lower Return on Assets (0.8%) than the US Drug Manufacturers - Specialty & Generic industry average (3.23%)
Performance

ENDP Return on capital employed

Current Company
6.19%
Current Industry
5.7%
ENDP has gotten more efficient at generating Return on Capital (6.19%) compared to 3 years ago (-7.84%)
Performance

ENDP earnings dates

Next earnings date
Nov 4, 2021

Endo International Earnings & Revenue FAQ

What were ENDP's earnings last quarter?

On Invalid Date, Endo International (NASDAQ: ENDP) reported Q2 2021 earnings per share (EPS) of -$0.07, up 240% year over year. Total Endo International earnings for the quarter were -$15.50 million. In the same quarter last year, Endo International's earnings per share (EPS) was $0.05.

What was ENDP's earnings growth in the past year?

As of Q4 2021, Endo International's earnings has grown null year over year. Endo International's earnings in the past year totalled $69.48 million.

What is ENDP's earnings date?

Endo International's earnings date is Invalid Date. Add ENDP to your watchlist to be reminded of ENDP's next earnings announcement.

What was ENDP's revenue last quarter?

On Invalid Date, Endo International (NASDAQ: ENDP) reported Q2 2021 revenue of $713.83 million up 3.82% year over year. In the same quarter last year, Endo International's revenue was $687.59 million.

What was ENDP's revenue growth in the past year?

As of Q4 2021, Endo International's revenue has grown -5.84% year over year. This is 24.1 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 18.26%. Endo International's revenue in the past year totalled $2.83 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.